Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study). (2019)

First Author: Waitt C
Attributed to:  Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1002895

PubMed Identifier: 31539371

Publication URI: http://europepmc.org/abstract/MED/31539371

Type: Journal Article/Review

Volume: 16

Parent Publication: PLoS medicine

Issue: 9

ISSN: 1549-1277